factually
Index/Topics/Teplizumab Approval 2022

Teplizumab Approval 2022

The approval of teplizumab for delaying the onset of type 1 diabetes in some patients.

Fact-Checks

2 results
Jan 14, 2026
Most Viewed

What are the diagnostic differences and treatment implications between type 2 diabetes and LADA (latent autoimmune diabetes in adults)?

Latent autoimmune diabetes in adults (LADA) lies on the diabetes spectrum between classic type 1 and type 2: it is an autoimmune, adult-onset form that initially resembles type 2 but progresses toward...

Jan 6, 2026

Has the FDA or other regulators approved any diabetes treatments promoted by Dr. Oz?

No credible evidence shows that the U.S. Food and Drug Administration or other regulators have approved any diabetes treatment that was created by or officially promoted by Dr. Mehmet Oz; multiple fac...